Early 2024, Bibian Tullemans started as a postdoctoral researcher at the Synapse Research Institute. Her expertise lies in understanding the complex platelet signalling pathways and phenotyping within haemostasis and thrombosis. Herein, she assists in the development of a microfluidic platform to investigate platelet thrombotic responses under physiological conditions. Additionally, she monitors and performs clinical validation studies of novel devices and FDA studies. She is an all-round researcher with a broad study interest, specialized in the use of multiple devices and techniques, which makes her indispensable within the team.
Bibian graduated from her bachelor’s degree in Applied Science with a specialization in Life Sciences at Fontys University in Eindhoven in 2014. She continued her education with a master in Biomedical Sciences at Maastricht University (UM), which she successfully completed in 2016. During her master she specialised in the field of haemostasis with her graduate internship at the Department of Biochemistry at UM on the effects of anti-cancer agents on platelet function. She continued this research as a PhD student at the Cardiovascular Research Institute Maastricht (CARIM, UM) resulting in her thesis entitled “Tyrosine kinase inhibitors for cancer treatment: Effects on platelets” in 2021. Her career continued outside of academia, focusing on the research and development of a new point of care system to assess (platelet)dysfunctions in haemostasis. This was followed by a position at the experimental medicine department of the Radboud hospital, investigating the influence of platelets on immune cell training and characterizing patients with an immune disorder affecting coagulation.
